Home Infusion Therapy Market 2020 Statistics, Trend & Growth Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 11, 2020 (Market Insight Reports) —
Home Infusion Therapy Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

The global home infusion therapy market is projected to observe significant growth due to the increasing prevalence of chronic diseases. In addition, an upsurge in the global geriatric population is expected to further drive the market size by the end of the analysis period. Home infusion is generally used to manage complex conditions like immune globin therapy. Infusion therapy is touted to be an alternative to oral therapy. This treatment involves administering medicines directly into the veins using a sterile catheter.

Request for a sample copy of this report @https://www.gminsights.com/request-sample/detail/435

In addition, the ongoing COVID-19 pandemic has further created immense demand for home infusion therapy with several industry players shifting their attention towards migrating crucial healthcare services to the comfort of COVID-19 patients’ homes. Taking April 2020 for instance, Option Care Health, a US-based home and alternate infusion services firm, reportedly partnered with health systems throughout the U.S. to transfer COVID-19 patients out of hospitals as soon as possible. The company intends to support hospitals by helping with patient discharge who need infusion therapy.

Following is an overview of some of the top trends that would outline the global home infusion therapy market outlook over 2020-2026:

Increasing adoption of needleless connectors

In terms of product, the market is bifurcated into intravenous sets, infusion pumps, needleless connectors, and IV cannulas. Of these, the needleless connectors segment is slated to foresee immense growth over the coming years as they provide enhanced safety, enable smoother surgeries, and also help in physicians adhere to better clinical practices.

In 2019, the segment was valued at about $6.2 billion and is further forecast to record a remunerative growth graph through 2026.

Steadily growing geriatric population

With respect to application, the industry is categorized into anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, and specialty pharmaceuticals. Of these, the steadily growing geriatric population across the globe is expected to driving the parenteral nutrition segment share.

In addition, an increasing number of malnourished children as well as a high natality rate across the world is likely to further complement the segment size. The population that falls under the aforementioned categories finds it difficult to consume nutrition from the oral route, which is increasing parenteral nutrition demand. Based on these factors, the segment is projected to expand at about 12% through the study period.

Increasing home infusion therapy demand from Latin America

The region’s growing geriatric population is likely to drive the Latin America home infusion therapy market over the coming years. According to the National Center for Biotechnology Information, there are an estimated 71 million people aged 60 or above in Latin America and the Caribbean, which represents 11.2% of the total regional population. In 2019, the market held a valuation of $948 million with industry forecasts expecting the segment to observe similar revenue expansion trends through 2026.

Request for customization @https://www.gminsights.com/roc/435

Gauging the potential growth opportunities, several market players are actively investing in a variety of growth strategies to spread awareness regarding the benefits of parenteral and enteral nutrition. Taking October 2018 for instance, Baxter International, a global leader in clinical nutrition, launched a video series in collaboration with ASPEN (American Society of Parenteral and Enteral Nutrition) to spread more awareness about the appropriate utilization of parenteral nutrition. Such efforts are likely to bring new interests to the industry, augmenting product adoption.

The competitive landscape of the global home infusion therapy market is inclusive of players such as Smiths Medical, ICU Medical, Fresenius Kabi, Becton Dickinson, B Braun Melsungen AG, and Baxter International among others.

Partial Chapter of the Table of Content

Chapter 4. Global Home Infusion Therapy Market, By Product

4.1. Key segment trends

4.2. Infusion Pump

4.2.1. Market size, by region, 2015-2026 (USD Million)

4.3. Intravenous sets

4.3.1. Market size, by region, 2015-2026 (USD Million)

4.4. IV cannulas

4.4.1. Market size, by region, 2015-2026 (USD Million)

4.5. Needleless connectors

4.5.1. Market size, by region, 2015-2026 (USD Million

Chapter 5. Global Home Infusion Therapy Market, By Application

5.1. Key segment trends

5.2. Anti-infective

5.2.1. Market size, by region, 2015-2026 (USD Million)

5.3. Hydration therapy

5.3.1. Market size, by region, 2015-2026 (USD Million)

5.4. Chemotherapy

5.4.1. Market size, by region, 2015-2026 (USD Million)

5.5. Enteral Nutrition

5.5.1. Market size, by region, 2015-2026 (USD Million

5.6. Parenteral Nutrition

5.6.1. Market size, by region, 2015-2026 (USD Million

5.7. Others

5.7.1. Market size, by region, 2015-2026 (USD Million)

Browse full table of contents (TOC) of this report @https://www.gminsights.com/toc/detail/home-infusion-therapy-market-report

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on [email protected]


Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article